Canada markets close in 1 hour 22 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.15-0.28 (-0.98%)
As of 02:38PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
198,709
160,257
101,808
68,604
Selling General and Administrative
54,880
48,019
54,225
39,513
Total Operating Expenses
253,589
208,276
156,033
108,117
Operating Income or Loss
-253,589
-208,276
-156,033
-108,117
Interest Expense
-
-
-
0
Total Other Income/Expenses Net
-10,565
-10,253
-781
328
Income Before Tax
-244,105
-210,951
-156,814
-107,789
Income Tax Expense
-656
9
-84
-358
Income from Continuing Operations
-243,449
-210,960
-156,730
-107,431
Net Income
-243,449
-210,960
-156,730
-107,431
Net Income available to common shareholders
-243,449
-210,960
-156,730
-107,431
Basic EPS
-1.96
-1.71
-1.43
-1.22
Diluted EPS
-1.96
-1.71
-1.43
-1.22
Basic Average Shares
130,197
123,075
109,679
87,757
Diluted Average Shares
130,197
123,075
109,679
87,757